Mr Andrew F Khouri

KANDO id: 36853

Bio

Joined Quaker BioVentures as an Analyst in September 2008. Previously: Consultant at Leerink Swann Strategic Advisors, a life sciences strategy consulting firm. Conducted multiple engagements for global pharmaceutical, biotech, and medical device clients. Projects included commercial assessments, clinical and development strategy, launch planning facilitation, product life cycle management and L&A due diligence. Engagements spanned numerous therapeutic areas, including oncology, rheumatology, neurology and infectious disease. Performed research studying the epigenetics of leukemia at Ohio State University Comprehensive Cancer Center. BA in Biology from Harvard University.

Education